Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline
- PMID: 35973173
- DOI: 10.14309/ajg.0000000000001896
Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline
Comment in
-
Response to Rajendra.Am J Gastroenterol. 2022 Nov 1;117(11):1881-1882. doi: 10.14309/ajg.0000000000002012. Am J Gastroenterol. 2022. PMID: 36327439 No abstract available.
Comment on
-
Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline.Am J Gastroenterol. 2022 Apr 1;117(4):559-587. doi: 10.14309/ajg.0000000000001680. Am J Gastroenterol. 2022. PMID: 35354777 Free PMC article.
References
-
- Shaheen NJ, Falk GW, Iyer P, et al. Diagnosis and management of Barrett's esophagus: An updated ACG guideline. Am J Gastroenterol 2022;117:559–87.
-
- Rajendra S, Wang B, Snow ET, et al. Transcriptionally active human papillomavirus is strongly associated with Barrett's dysplasia and esophageal adenocarcinoma. Am J Gastroenterol 2013;108:1082–93.
-
- Li X, Gao C, Yang Y, et al. Systematic review with meta-analysis: The association between human papillomavirus infection and oesophageal cancer. Aliment Pharmacol Ther 2014;39:270–81.
-
- Rajendra S, Yang T, Xuan W, et al. Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway. Int J Cancer 2017;141:2037–49.
-
- Snyder P, Dunbar K, Cipher DJ, et al. Aberrant p53 immunostaining in Barrett's esophagus predicts neoplastic progression: Systematic review and meta-analyses. Dig Dis Sci 2019;64:1089–97.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical